GLP-1 News & Analysis
Weekly pricing updates, FDA alerts, and expert analysis on the fast-moving GLP-1 landscape.
How to Get Semaglutide Online in 2026: The Fastest, Cheapest Legit Path
You can get semaglutide online in about 10 minutes without ever leaving home: complete a telehealth intake, get reviewed by a licensed US clinician, and have compounded semaglutide — the same active molecule as Ozempic and Wegovy — shipped to your door, often within a week. Cash price runs $69-$99/month through verified providers, versus $1,000-$1,350 for brand-name at the pharmacy. There's no in-person visit, no prior insurance approval, and no waiting-room. This is the exact step-by-step path: what you need, what it costs, how to spot a legitimate pharmacy from a sketchy one, and the fastest verified providers to start with today.
Why Am I Not Losing Weight on Ozempic? How to Break a GLP-1 Plateau (2026)
If the scale has stalled on Ozempic, the reasons are usually fixable: you're still on a starter dose that was never meant to be a treatment dose, your body has adapted to a new set point, or lost muscle has slowed your metabolism. Plateaus are normal — in the STEP trials, semaglutide weight loss naturally flattened around week 60. The fixes, in order: confirm you're truly plateaued (3+ weeks, not a normal 1-2 lb fluctuation), make sure you've titrated to a therapeutic dose, protect muscle with protein and resistance training, and reassess portions as your appetite returns. And if you've maxed out semaglutide with an inadequate response — about 14% of people are low responders — switching to tirzepatide is the evidence-based next step: it produced 20.2% body-weight loss vs semaglutide's 13.7% in the SURMOUNT-5 head-to-head. Here's how to diagnose your plateau and the exact order to fix it.
Is Berberine 'Nature's Ozempic'? What the Science Actually Says (2026)
Berberine has been nicknamed 'nature's Ozempic' on social media — but the science doesn't back it up. A meta-analysis of 12 trials found berberine produces about 4.5 pounds of weight loss (and one review found no significant effect on body weight), versus roughly 15% of body weight with semaglutide, the drug in Ozempic and Wegovy. Berberine is a plant supplement that isn't FDA-approved for weight loss, works through a different mechanism, and can interact with common medications. Here's what berberine actually does, whether it's safe, and — if brand-name prices are why you're looking — the genuinely affordable way to get real GLP-1 results.
How to Manage GLP-1 Side Effects: Nausea, Constipation & Diarrhea Relief (2026)
The most common GLP-1 side effects — nausea, constipation, and diarrhea — are almost always manageable at home and tend to fade after the first few weeks. Nausea: eat smaller, blander, lower-fat meals and stop when full. Constipation: add fiber gradually, hydrate, move, and ask your provider about a stool softener or osmotic laxative. Diarrhea: hydrate with electrolytes, stick to bland foods, and cut greasy or sugary items. Symptoms are worst after dose increases, so a slower titration helps. Here's the full relief playbook for each — plus the red flags that mean call your doctor.
Can You Drink Alcohol on Ozempic, Wegovy & Zepbound? What to Know (2026)
Yes — you can drink alcohol on Ozempic, Wegovy, Zepbound, Mounjaro, and compounded semaglutide or tirzepatide. There's no direct drug interaction, and the FDA labels carry no alcohol warning. But there are three real caveats: alcohol can worsen nausea and GI side effects, it raises low-blood-sugar risk (especially if you're also on diabetes medication), and it works against your weight-loss goal. Many people also notice they simply want to drink less on GLP-1s — an effect now backed by clinical research. Here's what's safe, what to watch, and why your tolerance may feel different.
Does Ozempic Need to Be Refrigerated? GLP-1 Storage & Travel Guide (2026)
Yes — store Ozempic and every GLP-1 (Wegovy, Mounjaro, Zepbound, and compounded semaglutide/tirzepatide) in the refrigerator at 36–46°F before first use. After first use, most can sit at room temperature for a limited window: Ozempic up to 56 days, Wegovy up to 28 days, Mounjaro and Zepbound single-dose up to 21 days (KwikPens up to 30). Never freeze them, and never use one that's frozen. Here's the full storage-and-travel guide — exact room-temp limits per drug, how to fly with your GLP-1, and what to do if it's left out.
How to Inject Ozempic, Wegovy, Mounjaro & Compounded GLP-1: Injection Sites + Step-by-Step (2026)
GLP-1 medications — Ozempic, Wegovy, Mounjaro, Zepbound, and compounded semaglutide or tirzepatide — are injected just under the skin (subcutaneously) once a week, into one of three sites: the abdomen (at least 2 inches from your navel), the front or outer thigh, or the back of the upper arm. You rotate the site each week to protect your skin. Here's the full step-by-step for both prefilled pens and vial-and-syringe, exactly where to inject, how to rotate, how to make it nearly painless, and the common mistakes to avoid — always alongside your prescriber's instructions and your device's guide.
Zepbound for Sleep Apnea 2026: How It Works, Trial Results, Cost & How to Get It
Zepbound (tirzepatide) is the first and only FDA-approved medication for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity — approved December 2024. In the SURMOUNT-OSA trial it cut sleep apnea severity (AHI) by an average of 55%, and up to 51.5% of participants improved enough to meet the criteria for disease resolution, alongside 18% body-weight loss. Here's how it works for OSA, who qualifies, what it costs, whether insurance covers it (often better than for weight loss alone), and how it fits alongside CPAP.
Foundayo Cost 2026: What Orforglipron Actually Costs With and Without Insurance
Foundayo (orforglipron) costs $149/month cash through LillyDirect — no insurance needed — which makes Eli Lilly's weight-loss pill dramatically cheaper than injectable brands that list at $1,000–$1,350. With Medicare you pay $50/month through the Bridge; with commercial insurance that covers it, about $25 with a savings card. Here's every way to pay for Foundayo in 2026, what each path really costs, who qualifies, and how the $149 pill stacks up against $69–$149 compounded GLP-1s.
Foundayo Dosage Guide 2026: The Full Orforglipron Titration Schedule (0.8mg → 17.2mg)
Foundayo (orforglipron) starts at 0.8 mg once daily and steps up every 4 weeks — through 5.5 mg, 9 mg, to a maximum of 17.2 mg. The starter dose isn't a treatment dose; it's there to build GI tolerance. You take it once a day, any time, with or without food or water — the only oral GLP-1 with no food restriction. Here's the full titration schedule, what to expect at each dose, missed-dose rules, and the dose that actually drives weight loss.
Foundayo (Orforglipron) 2026: Complete Guide to Cost, Dosage, Side Effects, Results & How It Compares
Foundayo (orforglipron) is Eli Lilly's oral GLP-1 pill for weight loss — FDA approved April 1, 2026, the first that works with no food or water restrictions. It costs $149/month cash via LillyDirect (or $50/month on the Medicare Bridge), and in the ATTAIN-1 trial the top dose produced up to 12.4% body-weight loss — meaningful, but below injectable tirzepatide (~20%) and semaglutide (~15%). Here's the complete guide: real cost, the full dosage schedule, side effects, how it compares to Wegovy and Zepbound, how to get it, and who should choose the pill vs an injectable.
Zepbound Savings Card 2026: Who Qualifies, How to Get $25/Month, and What to Do If Your Plan Says No
Eli Lilly's Zepbound Savings Card can drop your cost to as little as $25/month — but only if you have commercial insurance that actually covers Zepbound for weight loss. If your plan excludes weight-loss drugs (many still do), the card only brings the ~$1,089 price down to about $650. On Medicare or Medicaid, federal law blocks the card entirely. Here's exactly who qualifies, how to enroll in 10 minutes, the prior-auth appeal path, and the cheapest legitimate route to the same tirzepatide molecule — $149–$299/month compounded — when the $25 card isn't available to you.
Wegovy Savings Card 2026: Who Qualifies, How to Enroll, and What to Do If It Doesn't Work
Novo Nordisk's Wegovy Savings Card can drop your cost to as little as $0–$25/month — but only if you have commercial insurance that actually covers Wegovy for weight loss, and roughly half of employer plans don't. If you're on Medicare or Medicaid, federal law blocks the card entirely. Here's exactly who qualifies, how to enroll in 10 minutes, the appeal path when your plan says no, and the cheapest legitimate route to the same semaglutide — $99–$179/month compounded — when the card isn't available to you.
How to Get Ozempic (or Any GLP-1) in 2026: Every Path to a Prescription, Ranked by Speed and Cost
There are three ways to get Ozempic, Wegovy, Mounjaro, Zepbound, or their compounded equivalents in 2026 — and the fastest isn't your doctor's office. A licensed telehealth visit takes about 10 minutes online, a US prescriber reviews it same-day, and the medication ships to your door, often within a week. Through insurance a savings card can drop you to $25/month; cash-pay compounded starts at $99. Here's exactly how to get each GLP-1, whether you qualify (BMI ≥30, or ≥27 with a comorbidity, or Type 2 diabetes), and the step-by-step for the fastest route.
GLP-1 & Weight Loss Injections Near Me 2026: Why Telehealth Beats the Local Clinic (and Costs Less)
Searching "semaglutide near me" or "weight loss injections near me"? Here's the thing most people don't realize in 2026: you don't need a local clinic. Licensed US telehealth providers prescribe the same semaglutide and tirzepatide — the exact molecules in Ozempic, Wegovy, and Zepbound — after an online visit and ship them to your door in all 50 states, usually for less than a local med-spa charges. Local clinics often mark the same compounded vials up to $400-$600/month; telehealth starts at $99. Here's how "near me" actually works for GLP-1, what to check, and the verified programs that deliver anywhere.
Best GLP-1 for Weight Loss 2026: All 6 Ranked by Real Results, Cost, and Who Each One Suits
On raw efficacy the answer is settled: tirzepatide (Zepbound, Mounjaro, or compounded) leads at 20-22% average body weight loss, beating semaglutide's 15% in the only head-to-head trial. But "best" isn't one drug — it's the one your insurance covers, your gut tolerates, and your budget sustains for 12+ months, because time on the medication predicts results more than which molecule you picked. Here's every GLP-1 ranked by real trial data, what each costs on every path, and the decision matrix that tells you which is actually best for your situation.
Is Compounded Semaglutide Safe? What to Verify Before You Buy (2026 Trust Checklist)
Compounded semaglutide is the same active molecule as Ozempic and Wegovy, and it's safe when it comes from an FDA-registered US 503A pharmacy with a licensed prescriber. The real danger isn't compounding itself — it's unregulated sources: overseas 'research peptides,' sites with no prescriber, and pharmacies that won't name their partner or share testing. Here's exactly what to verify before you buy, the 7 red flags that mean walk away, and which verified programs clear the bar.
GLP-1 Dosage Chart 2026: Every Titration Schedule for Ozempic, Wegovy, Mounjaro, Zepbound & Compounded (Full Reference)
The complete GLP-1 dosage reference: side-by-side titration schedules for semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound), plus how compounded dosing maps to each. Every molecule starts low and steps up every 4 weeks to build tolerance — the starter dose is never a treatment dose. Includes the full week-by-week charts, missed-dose rules, dose-conversion math when switching molecules, injection how-to, and the cost trap where brand pricing scales with dose while compounded stays flat.
Zepbound Dosage Guide 2026: Titration Schedule, What Dose Actually Works, Missed-Dose Rules, and Cost Per Dose Tier
Zepbound starts at 2.5 mg/week and titrates every 4 weeks through 5, 7.5, 10, 12.5, and 15 mg. The 2.5 mg starter dose is not a treatment dose — it exists to build GI tolerance. Most patients see meaningful weight loss from 5-10 mg, and many never need 15 mg. The overlooked cost trap: brand Zepbound pricing scales with dose (LillyDirect vials run $349/mo at 2.5 mg but $499/mo at 7.5+ mg), while compounded tirzepatide is flat-priced at any dose ($149-$299/mo). Here's the full titration schedule, the dose-by-dose expectations, missed-dose rules, plateau protocol, and the cost math at every tier.
Medicare GLP-1 Bridge Program Launched Today (July 1, 2026): What Actually Happens Now, First-Week Playbook, and What to Do If You're in the Gap
The Medicare GLP-1 Bridge Program officially started dispensing at $50/month today, July 1, 2026. CMS estimates 3.4 million Medicare Part D enrollees qualify in year one. Here's what to do this week: confirm your Part D plan is participating, get your prescriber to submit the Bridge prior-auth, expect 5-14 day approval turnaround, and know the fallback paths if you're in the eligibility gap. Plus: the three most common day-1 confusion points and how to avoid them.
Ozempic Alternatives 2026: 9 Legitimate Options Ranked by Cost, Efficacy, and Situation
The best Ozempic alternative depends on why you'd switch. For higher weight loss, tirzepatide (Mounjaro, Zepbound, or compounded) beats semaglutide by ~47% in head-to-head trials. For lower cost, compounded semaglutide at $99/mo delivers the same active molecule for a tenth of retail. For insurance coverage of obesity (not diabetes), Wegovy is the correct sister brand. For oral, Rybelsus and Foundayo eliminate injections. Here's every legitimate Ozempic alternative in July 2026, ranked by what you're actually trying to solve.
Hims + Hers GLP-1 vs Compounded Semaglutide 2026: What You Actually Pay, What You Get, and Who Should Pick Which
Hims and Hers (same parent company, HIMS) sell compounded semaglutide starting at $199/month plus a $99 physician consultation and shipping fees — the real all-in first-month cost lands closer to $325 before the price stabilizes at $199/mo on refills. That's ~2× the market floor at Embody ($99/mo) and roughly matches TrimRx ($199/mo) and Yucca Health ($146/mo on 6-month). Here's what Hims and Hers actually deliver, the honest cost comparison, and who should pick which of the 6 verified compounded programs.
Zepbound Coupon 2026: Every Legitimate Discount, LillyDirect Vials, and the $99/mo Compounded Alternative
There is no traditional "Zepbound coupon" — Eli Lilly doesn't distribute discount codes the way retail brands do. What DOES exist: the Zepbound Savings Card ($25/mo with commercial insurance), LillyDirect self-pay vials ($349-$499/mo), the new Medicare GLP-1 Bridge Program ($50/mo launched July 1), and compounded tirzepatide at $99-$349/mo from US 503A pharmacies. Here's every legitimate way to lower your Zepbound cost in July 2026, what the fake "coupon code" sites actually deliver, and which path fits your situation.
Ro Weight Loss Review 2026: What You Actually Get, What You Pay, and 6 Cheaper Verified Alternatives
Ro (formerly Roman) sells brand-name Wegovy at $299/mo and "Body Bundle" plans starting at $145/mo. It's the most-searched telehealth GLP-1 brand and one of the most polished user experiences — but you're paying a substantial premium for the brand cachet, and Ro's compounded semaglutide costs 2-3× more than programs offering the same molecule. Here's what Ro actually delivers, the real all-in monthly cost after fees, and the 6 verified alternatives (starting at $99/mo) that offer the same molecule with equivalent or better clinical supervision.
Ozempic Face: What's Actually Happening, Why It Isn't Ozempic-Specific, and the Body-Comp Protocol That Prevents It (July 2026)
"Ozempic face" is the media name for something that happens on any weight-loss intervention: rapid loss of subcutaneous facial fat, which sits closer to the surface than trunk fat and shows first. It happens on Wegovy, Mounjaro, Zepbound, bariatric surgery, and any diet that drops weight faster than about 1% body weight per week. The physiology is well-understood — and so is the prevention protocol: slow your weight-loss pace to <1% per week, protein at 1.2 g/kg/day, resistance training 2-3× per week, hydration, sleep. Here's the actual mechanism, who's at highest risk, how to prevent it, and the four cheaper paths that make slower titration financially feasible.
Mounjaro Side Effects: Realistic Week-by-Week Timeline, Tirzepatide-Specific Differences, and When to Stop (June 2026)
Nausea hits 18-22% of Mounjaro patients in SURPASS trials. Constipation hits 17%, diarrhea 17%, vomiting 8-13%. The tirzepatide-specific pattern: more constipation than semaglutide (GIP receptor's effect on gut motility), more weight loss, and the GI tolerability profile peaks slightly later in titration. Most side effects resolve in 4-6 weeks; constipation can persist for months. Here's the realistic week-by-week timeline, what to actually do, the 5 red flags that mean stop, and the cheaper paths if Mounjaro's $1,069/month cash price is what would push you to quit before the side effects settle.
Ozempic Side Effects: Realistic Week-by-Week Timeline, What to Actually Do, and When to Stop (June 2026)
Nausea hits 44% of Ozempic patients in the first 4 weeks. Diarrhea hits 30%, constipation 24%, vomiting 24%. Most resolve in 2-4 weeks as your gut adapts — but the real reason patients quit isn't side effects alone, it's cost on top of side effects. Here's the realistic week-by-week side effect timeline, the management protocols that work (and the ones that don't), the five red flags that mean stop immediately, plus the cheaper paths that let you stay on long enough for the side effects to settle.
Zepbound vs Ozempic 2026: Different Drugs, Different Labels — Which One Wins for Weight Loss, Diabetes, and Cost?
Zepbound (tirzepatide, Eli Lilly) and Ozempic (semaglutide, Novo Nordisk) are different molecules from different makers, approved for different things — Zepbound for chronic weight management, Ozempic for Type 2 diabetes. In the SURMOUNT-5 head-to-head, tirzepatide produced 20.2% body weight loss vs 13.7% for semaglutide. But Ozempic has 8+ years of cardiovascular and kidney outcome data and broader diabetes coverage. Both savings cards drop you to $25/month with commercial insurance. Cash-pay: Zepbound vials $349-$499/mo, Ozempic retail $998/mo. Compounded tirzepatide runs $99-$349/mo; compounded semaglutide $99-$258/mo. Here's the head-to-head by clinical fit, cost, and the cheapest legitimate path for each.
Ozempic vs Wegovy 2026: Same Molecule, Different Label — Which One Should You Take? (Cost, Dose, Insurance)
Ozempic and Wegovy are the exact same active molecule (semaglutide) from the exact same manufacturer (Novo Nordisk). The differences come down to FDA indication (T2D vs obesity), max dose (2.0 mg vs 2.4 mg), and how insurance treats them. If you have Type 2 diabetes, Ozempic is the right path — $25/mo via Savings Card. If you don't have T2D, Ozempic is off-label and won't be covered; Wegovy is the correct prescription — $25/mo with Savings Card if you qualify on BMI. Cash retail: Ozempic $998/mo, Wegovy $1,349/mo. Compounded: $99/mo via Embody, $146/mo via Yucca, $199/mo via TrimRx. Here's the full head-to-head and the cheapest legitimate path for each.
Wegovy Weight Loss: How Much Will You Actually Lose? Real Week-by-Week Results, Trial Data vs Real World (June 2026)
In the STEP-1 trial, the average patient lost 14.9% of body weight on Wegovy at 68 weeks. STEP-5 showed 15.2% at two years. But real-world data — including a 50,000-patient JAMA Internal Medicine study — shows real-world loss is closer to 6-8% on average, mostly because patients stop early. Here's the realistic week-by-week curve, the four factors that make you lose more (or less) than average, and the cheapest legitimate paths if Wegovy's price tag is the reason you'd quit early.
Mounjaro vs Ozempic 2026: Which T2D GLP-1 Wins for Weight Loss, A1C, and Cost? (Head-to-Head Comparison)
Mounjaro (tirzepatide) and Ozempic (semaglutide) are both FDA-approved only for Type 2 diabetes — but they're the two most-prescribed GLP-1s, on-label and off-label for weight loss. In the SURMOUNT-5 head-to-head trial, tirzepatide produced 20.2% body weight loss vs 13.7% for semaglutide. But Ozempic has 8+ years of cardiovascular and kidney outcome data. Both savings cards drop you to $25/month with insurance — and compounded versions of either start at $99/month. Here's the head-to-head by clinical fit, cost, and cheapest legitimate path.
How to Get Wegovy Covered by Insurance in 2026: Prior Authorization Playbook, Denial Codes, and Appeal Letter Template
Roughly 40% of Wegovy prior authorization requests are denied on first submission — and most denials are reversible. Here's exactly what insurers require (BMI ≥30, or ≥27 with one of 6 comorbidities), what to bring to your visit, the four documentation gaps that trigger 80% of denials, how to win a peer-to-peer review, a copy-paste appeal letter template, and the 4 cheaper paths if your plan refuses to cover it.
Ozempic for PCOS: Does It Work? Cost, Dosing, and the 4 Cheaper Compounded Paths When Insurance Says No (June 2026)
GLP-1s like Ozempic and Wegovy aren't FDA-approved for PCOS — but they directly target the insulin resistance that drives PCOS weight gain, irregular cycles, and acne. The catch: without a Type 2 diabetes or obesity ICD-10 code, insurance almost always denies coverage. Cash-pay brand Ozempic runs $998/month. Here are the four legitimate cheaper paths for PCOS patients in June 2026, the trial data behind GLP-1 for PCOS, and the dose-conversion logic if you're stacking with metformin.
Tirzepatide vs Semaglutide: Which GLP-1 Molecule Wins in 2026? (Cost, Weight Loss, Side Effects Compared)
Tirzepatide (Mounjaro, Zepbound, compounded) drives 22.5% body weight loss in trials vs 15% for semaglutide (Ozempic, Wegovy, compounded). But semaglutide has 7+ years of real-world data, broader insurance coverage, and an oral pill option (Rybelsus). Here's the head-to-head on mechanism, efficacy, side effects, and the cheapest verified path for each — by your situation.
Mounjaro for Weight Loss: How It Works, What It Costs Off-Label, and the 3 Cheaper Paths in June 2026
Mounjaro (tirzepatide) is FDA-approved only for Type 2 diabetes — but it's the same active molecule as Zepbound, which is approved for weight loss. If you're paying $1,069/month cash-pay for off-label Mounjaro, there are three legitimate cheaper paths: get a prediabetes diagnosis to unlock the $25 Savings Card, switch to brand Zepbound, or move to compounded tirzepatide at $99-$249/month. Here's the decision tree.
Is Compounded Semaglutide Getting Banned? What the FDA's 503B Proposal Actually Means — And Where You Can Still Buy It (June 2026)
The FDA has proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulks List — the comment period closes June 29, 2026. If finalized, large-scale outsourcing facilities lose their compounding pathway. But 503A patient-specific pharmacies operate under separate rules, and that's where the market is already moving. Here's what's actually banned, what isn't, the questions to ask your provider this week, and which programs are positioned to keep shipping.
Medicare GLP-1 Bridge Program: Do You Qualify for $50/Month — And What to Do If You Don't (July 2026)
Medicare's $50/month GLP-1 Bridge Program launches July 1, 2026, covering Wegovy, Zepbound, and Foundayo. But the eligibility tiers are stricter than most headlines suggest: BMI ≥35, or ≥30 with heart failure/hypertension/CKD, or ≥27 with prediabetes or prior heart attack/stroke. Here's exactly who qualifies, how enrollment actually works (your doctor submits — you can't), and the cheapest legitimate options if you're in the gap.
How to Get Wegovy Cheaper in June 2026: 7 Real Paths from $25 to $1,349/Month (Before the July 1 Medicare Launch)
Wegovy lists at $1,349/month but most patients never pay that. The seven legitimate cheaper paths in June 2026: $25/mo Wegovy Savings Card (insured), $50/mo Medicare bridge (starts July 1), $25/mo Ozempic Savings Card (if T2D), $249/mo NovoCare direct, $99-249/mo compounded semaglutide, $149/mo oral Foundayo, and $1,349/mo retail. Here's exactly which path fits your situation — and the timing trick if you're 24 days from Medicare launch.
How to Switch from Ozempic to Compounded Semaglutide (June 2026): 6 Programs, Dose Conversion, Step-by-Step
If you're paying $700-$1,000/month for Ozempic and your insurance dropped semaglutide coverage, compounded semaglutide is the same active molecule for $99-$199/month from a licensed US telehealth pharmacy. Here's the exact dose conversion, the 6 programs that ship reliably in June 2026, and the timing trick to switch without losing weight-loss progress.
Cheapest Compounded Semaglutide Online: 7 Verified Programs Ranked (June 2026)
Compounded semaglutide — same active molecule as Ozempic and Wegovy — is available from licensed US telehealth providers starting at $99/month. We compared June 2026 pricing, pharmacy partners, LegitScript status, shipping speed, and what happens if FDA removes semaglutide from the shortage list. Here's where to actually buy it.
How to Get Zepbound Cheaper in 2026: 6 Real Paths from $25 to $349/Month
Zepbound lists at $1,089/month but real-world cost ranges from $25 (Lilly Savings Card) to $349 (LillyDirect vials) to $99 (compounded tirzepatide). Here's every legitimate path to get Zepbound's molecule cheaper in May 2026 — including the Mounjaro route most patients miss.
Cheapest Compounded Tirzepatide Online: 6 Verified Programs Compared (May 2026)
Compounded tirzepatide — the same active ingredient in Zepbound and Mounjaro — is available from licensed US telehealth providers starting at $99/month. We verified pricing, pharmacy partners, credentialing, and shipping speed for the 6 cheapest legitimate programs in May 2026.
Ozempic Long-Term Safety: What 90,000-Patient Heart & Kidney Studies Reveal (May 2026)
New May 2026 research: GLP-1s cut major cardiovascular events 13-26%, sharply lower kidney disease and sleep apnea risk — but stopping for just 6 months erases the protection. Here's what 90,000+ patients reveal about staying on Ozempic long-term, and the cheapest providers if cost is the reason you'd quit.
Best Wegovy Alternatives in 2026 (By Cost, Effectiveness, Insurance)
Wegovy works, but it's not the only path. In 2026 the legitimate alternatives range from more potent ($349/mo Zepbound vials) to cheaper ($149/mo Foundayo pill, $99/mo compounded semaglutide) to insurance-friendlier (Mounjaro if you have diabetes). Here's the head-to-head comparison and which alternative fits which patient.
Does Zepbound Cause Hair Loss? What the Data Shows (2026)
Yes — about 5.7% of patients on the highest Zepbound dose report hair shedding in clinical trials, with real-world telehealth rates running 8-12%. It's almost always temporary telogen effluvium driven by rapid weight loss, not the drug itself. Here's how to prevent it, treat it, and which providers actually screen for it.
How to Get Mounjaro for $25 a Month (2026 Savings Card Guide)
Eli Lilly's Mounjaro Savings Card drops your copay to $25/month — but only for commercially insured patients with a type 2 diabetes diagnosis. Here's exactly who qualifies, how to enroll, what to do if your insurance refuses prior auth, and the legitimate paths if $25 isn't available to you.
How Long Do Zepbound Side Effects Last? (2026 Timeline by Side Effect)
Most Zepbound side effects start within 24-72 hours of an injection and resolve in 1-2 weeks at each new dose level. Nausea peaks first; fatigue and constipation linger longer. Here's the timeline by symptom — and when persistent side effects mean it's time to adjust your dose.
Is Zepbound the Same as Mounjaro? Yes — Here's What That Means for Your Cost (2026)
Same molecule (tirzepatide), same manufacturer (Eli Lilly), same dose strengths — different FDA label. Mounjaro is approved for type 2 diabetes; Zepbound is approved for chronic weight management. Here's how that affects your cost, insurance coverage, and how to access the cheapest legitimate path in 2026.
Can You Stay on a Low Dose of Wegovy? Maintenance Dose Guide (2026)
Yes — and most patients who hit their goal weight should. The FDA label says 2.4 mg, but real-world clinical practice routinely uses 1.0–1.7 mg (or lower) for maintenance. Here's what works, what insurance will pay for, and which providers will actually customize your dose.
Is Zepbound Better Than Wegovy? Head-to-Head 2026 (Cost, Results, Side Effects)
For most patients, yes. Zepbound delivers ~20% mean weight loss vs Wegovy's ~14% in the head-to-head SURMOUNT-5 trial. But cost, side effects, and the new $149/month oral pills flip the answer for some patients. Here's the 2026 breakdown.
Ozempic & GLP-1 Hair Loss: What 84,000 Patients Reveal (May 2026)
A 2026 meta-analysis of 84,000 GLP-1 users found 3.4× higher hair-loss risk vs non-users. Here's why it happens, who it hits hardest, what stops it, and which providers help.
GLP-1 Microdosing: Does It Work? Cost, Providers & What the Science Says (2026)
GLP-1 microdosing — taking 0.05-0.125mg/week instead of standard 0.25-2.4mg — is trending. Here's what clinicians actually say, who offers it, and what it costs.
"Gut Reset" May Lock In GLP-1 Weight Loss After Quitting (New Study)
A new sham-controlled trial shows a minimally invasive gut procedure helped patients keep 80% of their GLP-1 weight loss after stopping tirzepatide. Here's what it means.
Quitting and Restarting Your GLP-1? What It Does to Your Muscles (2026)
Fewer than 1 in 4 patients stay on a GLP-1 after one year. Up to 40% of weight lost is muscle. Each stop-restart cycle makes it worse. Here's what the research says — and how to avoid the trap.
24 Million Americans Just Lost GLP-1 Coverage — Here's What Actually Happened
NPR reports 12 million lost Zepbound coverage and 12 million lost Wegovy coverage in the past year. CVS Caremark, BCBS Massachusetts, and Harvard Pilgrim all pulled back. Here's the full list — and what you can do right now.
Insurance Dropped Your GLP-1? 5 Cheapest Options (2026)
41 million Americans lost commercial GLP-1 coverage in 2026. CVS Caremark dropped Zepbound, BCBS restricted Wegovy. Here are the cheapest ways to keep your medication without insurance.
Your Genes May Predict How Much Weight You'll Lose on GLP-1s (New Study)
A massive 23andMe study published in Nature found genetic variants that predict GLP-1 weight loss (6-20%) and nausea risk (5-78%). Here's what it means for choosing your medication.
Hims Drops Compounded Semaglutide: What the Novo Nordisk Deal Means for You
Hims partnered with Novo Nordisk, stopped advertising compounded GLP-1s, and now offers FDA-approved Wegovy starting at $149/month. Here's what changes for patients.
Foundayo Ships Today: How to Get Eli Lilly's GLP-1 Pill for $149/Month
LillyDirect began shipping Foundayo on April 6, 2026. Here's exactly how to order, what it costs with and without insurance, and how it compares to every other GLP-1 option.
Medicare's GLP-1 Bridge and the CMS Balance Model: How 2026 Coverage Works (April 2026)
Medicare's GLP-1 Bridge launches July 1, 2026 — an 18-month demonstration running through December 31, 2027. CMS's separate Balance Model was adopted only in Medicaid, not Medicare. Here's what Part D patients need to know about eligibility and costs.
GLP-1 Price War 2026: Foundayo $25, Wegovy $249, Compounded $99 — Every Option Ranked
Foundayo at $25/mo with insurance ($149 self-pay), Wegovy subscription $249/mo, compounded tirzepatide from $99, Zepbound vials $349, Medicare Bridge $50 starting July. Updated May 2026 with every legitimate 2026 GLP-1 option ranked by total monthly cost.
FDA Approves Foundayo: The GLP-1 Pill You Take With Food (April 2026)
Eli Lilly's oral weight loss pill got the fastest FDA approval since 2002 on April 1, 2026. Here's how Foundayo compares to oral Wegovy at $149/month.
GLP-1 Pill War: What Orforglipron Means for You (April 2026)
Eli Lilly's oral GLP-1 pill gets its FDA decision April 10. Novo Nordisk just launched Wegovy subscriptions at $249/month. Here's what's happening now.
Medicare GLP-1 Bridge Program: 5 Things to Know Before July 2026
The $50/month Medicare GLP-1 Bridge launches July 1, 2026. Here are 5 things Part D enrollees must prepare now to lock in Wegovy, Zepbound, or Foundayo.
Oral Wegovy at 3 Months: What Early Users Report: 2026 Guide
Three months after the December 2025 launch, here's what real oral semaglutide patients say about weight loss, side effects, and the fasting requirement.
FDA Warns 12 More GLP-1 Compounders (March 2026 Update)
The FDA's March 2026 enforcement wave adds 12 new compounding pharmacies to the warning list, bringing the total past 40 since late 2025. Here's who was flagged.
GLP-1 Price Check: Cheapest Programs This Month (March 2026)
We tracked pricing across 15+ GLP-1 telehealth providers in March 2026. Here's who lowered prices, who raised them, and which compounded plan is cheapest now.
Orforglipron FDA Decision April 10: What It Means (April 2026)
Eli Lilly's oral non-peptide GLP-1 orforglipron faces its FDA PDUFA date April 10, 2026. Here's how this pill could reshape the weight loss landscape.
Stay Informed
We publish new analysis every week covering FDA decisions, provider pricing changes, and clinical trial results.